Intensive Care Unit
Yeşim Yıldız and others
Vaccines to prevent SARS-CoV-2 infection are the most promising and effective approach to curb the COVID-19 pandemic, as well as to reduce hospitalizations and prevent mortality. In our country, the CoronaVac (Sinovac Biotech, China) vaccine started to be administered as of January 13, 2021, and the Comirnaty (BNT162b2, Pfizer-BioNTech) vaccine as (...) Read More
Hande Özportakal and others
The world has been fighting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than two years, leading to more than 605 million cases and 6.4 million deaths as of September 11, 2022. Since the angiotensin-converting enzyme (ACE) is the functional receptor for SARS-CoV-2, predominantly expressed by the alveoli (...) Read More
Hasan Naz and others
Nosocomial infections (NIs) constitute a major health issue in terms of morbidity, high mortality, prolonged hospitalization, and increased costs of direct patient care. While beds in intensive care units (ICUs) constitute less than 10% of all hospital beds, more than 20% of all NIs develop in the ICU. The human lifespan has been prolonged (...) Read More
Mehmet Kürşat Bilgin and others
Fungal infections account for about 20% of all microbiological infections in critically ill patients. Candida species are the most common fungi in intensive care units (ICU) and mostly C. albicans. However, the rate of non-albicans Candida species such as C. tropicalis, C. krusei, C. parapsilosis, C. glabrata which are more resistant to antifungal therapy (...) Read More
Aral Sürmeli and others
Introduction The novel coronavirus (SARS-CoV-2) started in December 2019 in China, has infected over 4.2 million people worldwide, resulting in a death toll of 290 000 as of 13 May 2020 (1). It causes a multi-systemic infection named Coronavirus Disease 2019 (COVID-19). The symptoms reported are Read More